Anticonvulsants for preventing seizures in patients with chronic subdural haematoma

Area of Science:

• Neurosurgery
• Neurology
• Clinical Trials

Background:

• Prophylactic anticonvulsant therapy is sometimes administered to patients diagnosed with chronic subdural hematoma.
• The clinical benefit of using anticonvulsants in this patient population remains uncertain.
• Evidence supporting prophylactic anticonvulsant use in chronic subdural hematoma is limited.

Purpose of the Study:

• To evaluate the efficacy of prophylactic anticonvulsants in patients with chronic subdural hematoma.
• To assess treatment effects in both pre-operative and post-operative phases.
• To synthesize available evidence on anticonvulsant use for chronic subdural hematoma.

Main Methods:

• A comprehensive literature search was conducted across multiple databases including Cochrane, MEDLINE, EMBASE, PubMed, and LILACS.
• Searches included clinical trial registries such as clinicaltrials.gov and WHO ICTRP up to March 27, 2013.
• Inclusion criteria focused on randomized controlled trials comparing anticonvulsants against placebo or no intervention.

Main Results:

• The systematic review identified no randomized controlled trials that met the inclusion criteria.
• No studies provided high-quality evidence on the use of prophylactic anticonvulsants for chronic subdural hematoma.
• The lack of randomized controlled trials indicates a significant gap in the evidence base.

Conclusions:

• Formal recommendations regarding prophylactic anticonvulsant use in chronic subdural hematoma cannot be made due to the absence of robust evidence.
• Existing non-controlled studies present conflicting results, further complicating clinical decision-making.
• There is a critical need for well-designed randomized controlled trials to determine the true benefit of prophylactic anticonvulsants in this condition.